These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27235613)

  • 1. Movement Disorders: A Brief Guide in Medication Management.
    Julius A; Longfellow K
    Med Clin North Am; 2016 Jul; 100(4):733-61. PubMed ID: 27235613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movement disorders: a sleep specialist's perspective.
    Phillips B
    Neurology; 2004 Mar; 62(5 Suppl 2):S9-16. PubMed ID: 15007159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How best to address these common movement disorders.
    Yaman A; Akdeniz M; Yaman H
    J Fam Pract; 2011 Dec; 60(12):721-5. PubMed ID: 22163354
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches].
    Faludi B; Janszky J; Komoly S; Kovács N
    Orv Hetil; 2015 Jul; 156(27):1091-9. PubMed ID: 26122904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sleep disorders in Parkinson's disease: REM sleep behaviour disorder and restless legs syndrome].
    Jáuregui-Barrutia A; Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
    Rev Neurol; 2010 Feb; 50 Suppl 2():S15-9. PubMed ID: 20205137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of motor complications in Parkinson's disease.
    Dewey RB
    Neurology; 2004 Mar; 62(6 Suppl 4):S3-7. PubMed ID: 15037664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current guidelines and standards of practice for restless legs syndrome.
    Hening WA
    Am J Med; 2007 Jan; 120(1 Suppl 1):S22-7. PubMed ID: 17198767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract]   [Full Text] [Related]  

  • 9. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
    Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M
    Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK
    Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological treatment of parkinsonian tremor].
    Yokochi F
    Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the pharmacology of REM sleep behavior disorder.
    Gagnon JF; Postuma RB; Montplaisir J
    Neurology; 2006 Sep; 67(5):742-7. PubMed ID: 16966533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sleep disturbances in Parkinson's disease].
    Boczarska-Jedynak M; Opala G
    Neurol Neurochir Pol; 2005; 39(5):380-8. PubMed ID: 16273462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sleep disturbance in Parkinson's disease].
    Nomura T; Inoue Y; Nakashima K
    Rinsho Shinkeigaku; 2014; 54(12):987-90. PubMed ID: 25672688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restless legs, restless nights: therapeutic options in RLS].
    Kassubek J; Unrath A
    MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sleep and movement disorders].
    Poryazova R; Bassetti CL
    Ther Umsch; 2007 Jan; 64(1):63-72. PubMed ID: 17221827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence.
    Tarrants ML; Denarié MF; Castelli-Haley J; Millard J; Zhang D
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):374-83. PubMed ID: 20869623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbances in Parkinson's disease with emphasis on rapid eye movement sleep behavior disorder.
    Barber A; Dashtipour K
    Int J Neurosci; 2012 Aug; 122(8):407-12. PubMed ID: 22463496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome.
    Chazot PL
    Curr Opin Investig Drugs; 2007 Jul; 8(7):570-9. PubMed ID: 17659477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement Disorders in Women.
    Baker JM; Hung AY
    Semin Neurol; 2017 Dec; 37(6):653-660. PubMed ID: 29270938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.